3647 results for «482»
3647 results
Endocarditis: what can we suggest for the upcoming ESC guidelines?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the various challenges in treating patients with endocarditis, to understand how to better diagnose valve endocarditis and to discover new transcatheter interventions after endocarditis.
The challenge of aortic regurgitation: better imaging for better clinical practice
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn about the challenges of diagnosing aortic regurgitation and how to overcome them, to better understand the right timing for intervention based on available evidence, and to discover what tools exist to more accurately assess the severity of aortic regurgitation.
Imaging before and after TAVI - How to treat
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.
Where are we going? The symptomatic patient with moderate aortic stenosis
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.
Diagnosis of disease type and of disease severity
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.
Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)
31 Mar 2025
Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.
The manuscript for this trial has not been published and all assumptions are based upon the presentation.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
